Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A FACTOR IX (FIX) GENE TRANSFER, MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B

NCT03307980 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03307980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03307980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A FACTOR IX (FIX) GENE TRANSFER, MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
June 22, 2017
Completion date
July 23, 2026
Enrollment
21 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b